These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2137453)

  • 1. Dissociation of the effect of caldesmon on the ATPase activity and on the binding of smooth heavy meromyosin to actin by partial digestion of caldesmon.
    Velaz L; Ingraham RH; Chalovich JM
    J Biol Chem; 1990 Feb; 265(5):2929-34. PubMed ID: 2137453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of caldesmon on the ATPase activity and the binding of smooth and skeletal myosin subfragments to actin.
    Hemric ME; Chalovich JM
    J Biol Chem; 1988 Feb; 263(4):1878-85. PubMed ID: 2962997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caldesmon inhibits the cooperative turning-on of the smooth muscle heavy meromyosin by tropomyosin-actin.
    Horiuchi KY; Chacko S
    Biochemistry; 1989 Nov; 28(23):9111-6. PubMed ID: 2532547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of caldesmon binding to myosin.
    Hemric ME; Chalovich JM
    J Biol Chem; 1990 Nov; 265(32):19672-8. PubMed ID: 2246251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the myosin and tropomyosin binding regions of the smooth muscle caldesmon.
    Katayama E; Horiuchi KY; Chacko S
    Biochem Biophys Res Commun; 1989 May; 160(3):1316-22. PubMed ID: 2525036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for the inhibition of acto-heavy meromyosin ATPase by the actin/calmodulin binding domain of caldesmon.
    Horiuchi KY; Samuel M; Chacko S
    Biochemistry; 1991 Jan; 30(3):712-7. PubMed ID: 1824822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural study of gizzard caldesmon and its interaction with actin. Binding involves residues of actin also recognised by myosin subfragment 1.
    Levine BA; Moir AJ; Audemard E; Mornet D; Patchell VB; Perry SV
    Eur J Biochem; 1990 Nov; 193(3):687-96. PubMed ID: 2147415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caldesmon inhibits skeletal actomyosin subfragment-1 ATPase activity and the binding of myosin subfragment-1 to actin.
    Chalovich JM; Cornelius P; Benson CE
    J Biol Chem; 1987 Apr; 262(12):5711-6. PubMed ID: 2952642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of caldesmon on smooth muscle heavy actomeromyosin ATPase activity and binding of heavy meromyosin to actin.
    Lash JA; Sellers JR; Hathaway DR
    J Biol Chem; 1986 Dec; 261(34):16155-60. PubMed ID: 2946681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of actin stimulation of skeletal muscle (A1)S-1 ATPase activity by caldesmon.
    Hemric ME; Freedman MV; Chalovich JM
    Arch Biochem Biophys; 1993 Oct; 306(1):39-43. PubMed ID: 8215419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a caldesmon fragment that competes with myosin-ATP binding to actin.
    Velaz L; Chen YD; Chalovich JM
    Biophys J; 1993 Aug; 65(2):892-8. PubMed ID: 8218912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of smooth muscle heavy meromyosin to actin in the presence of ATP. Effect of phosphorylation.
    Sellers JR; Eisenberg E; Adelstein RS
    J Biol Chem; 1982 Dec; 257(23):13880-3. PubMed ID: 6128340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of caldesmon binding to smooth muscle thin filament: possible projection of the amino-terminal of caldesmon from native thin filament.
    Katayama E; Ikebe M
    Biophys J; 1995 Jun; 68(6):2419-28. PubMed ID: 7647246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the ATP-dependent interaction between actin and myosin by a myosin-binding fragment of smooth muscle caldesmon.
    Lin Y; Ishikawa R; Okagaki T; Ye LH; Kohama K
    Cell Motil Cytoskeleton; 1994; 29(3):250-8. PubMed ID: 7895289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of caldesmon by p21-activated kinase. Implications for the Ca(2+) sensitivity of smooth muscle contraction.
    Foster DB; Shen LH; Kelly J; Thibault P; Van Eyk JE; Mak AS
    J Biol Chem; 2000 Jan; 275(3):1959-65. PubMed ID: 10636898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aorta caldesmon inhibits actin activation of thiophosphorylated heavy meromyosin Mg2+-ATPase activity by slowing the rate of product release.
    Marston S
    FEBS Lett; 1988 Sep; 238(1):147-50. PubMed ID: 2971572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of smooth muscle caldesmon on actin filament motility.
    Haeberle JR; Trybus KM; Hemric ME; Warshaw DM
    J Biol Chem; 1992 Nov; 267(32):23001-6. PubMed ID: 1429647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of calponin on smooth and skeletal muscle actomyosin systems in the presence and absence of caldesmon.
    Winder SJ; Sutherland C; Walsh MP
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):733-9. PubMed ID: 1471986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of smooth muscle caldesmon to the NH2-terminal region of skeletal F-actin.
    Bartegi A; Fattoum A; Kassab R
    J Biol Chem; 1990 Feb; 265(4):2231-7. PubMed ID: 2298747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and characterization of a 7.3-kDa region of caldesmon which reversibly inhibits actomyosin ATPase activity.
    Chalovich JM; Bryan J; Benson CE; Velaz L
    J Biol Chem; 1992 Aug; 267(23):16644-50. PubMed ID: 1386604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.